Literature DB >> 10400792

Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway.

E Boritz1, J Gerlach, J E Johnson, J K Rose.   

Abstract

We describe a replication-competent, recombinant vesicular stomatitis virus (VSV) in which the gene encoding the single transmembrane glycoprotein (G) was deleted and replaced by an env-G hybrid gene encoding the extracellular and transmembrane domains of a human immunodeficiency virus type 1 (HIV-1) envelope protein fused to the cytoplasmic domain of VSV G. An additional gene encoding a green fluorescent protein was added to permit rapid detection of infection. This novel surrogate virus infected and propagated on cells expressing the HIV receptor CD4 and coreceptor CXCR4. Infection was blocked by SDF-1, the ligand for CXCR4, by antibody to CD4 and by HIV-neutralizing antibody. This virus, unlike VSV, entered cells by a pH-independent pathway and thus supports a pH-independent pathway of HIV entry. Additional recombinants carrying hybrid env-G genes derived from R5 or X4R5 HIV strains also showed the coreceptor specificities of the HIV strains from which they were derived. These surrogate viruses provide a simple and rapid assay for HIV-neutralizing antibodies as well as a rapid screen for molecules that would interfere with any stage of HIV binding or entry. The viruses might also be useful as HIV vaccines. Our results suggest wide applications of other surrogate viruses based on VSV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400792      PMCID: PMC112779     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

2.  The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody.

Authors:  J M Kelley; S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

Review 3.  The CD4 antigen: physiological ligand and HIV receptor.

Authors:  Q J Sattentau; R A Weiss
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

Review 4.  Viral pseudotypes and phenotypic mixing.

Authors:  J Závada
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

Review 5.  The entry of enveloped viruses into cells by endocytosis.

Authors:  M Marsh
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

6.  pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.

Authors:  B S Stein; S D Gowda; J D Lifson; R C Penhallow; K G Bensch; E G Engleman
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

7.  HIV infection does not require endocytosis of its receptor, CD4.

Authors:  P J Maddon; J S McDougal; P R Clapham; A G Dalgleish; S Jamal; R A Weiss; R Axel
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

8.  A new cationic liposome reagent mediating nearly quantitative transfection of animal cells.

Authors:  J K Rose; L Buonocore; M A Whitt
Journal:  Biotechniques       Date:  1991-04       Impact factor: 1.993

9.  Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism.

Authors:  M O McClure; M Marsh; R A Weiss
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

10.  Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis.

Authors:  C D Pauza; T M Price
Journal:  J Cell Biol       Date:  1988-09       Impact factor: 10.539

View more
  44 in total

1.  Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice.

Authors:  Andreas Pichlmair; Johanna Buse; Stephanie Jennings; Otto Haller; Georg Kochs; Peter Staeheli
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.

Authors:  John B Schell; Nina F Rose; Kapil Bahl; Kathryn Diller; Linda Buonocore; Meredith Hunter; Preston A Marx; Ratish Gambhira; Haili Tang; David C Montefiori; Welkin E Johnson; John K Rose
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Negative regulation of interferon-induced transmembrane protein 3 by SET7-mediated lysine monomethylation.

Authors:  Zhao Shan; Qinglin Han; Jia Nie; Xuezhi Cao; Zuojia Chen; Shuying Yin; Yayi Gao; Fang Lin; Xiaohui Zhou; Ke Xu; Huimin Fan; Zhikang Qian; Bing Sun; Jin Zhong; Bin Li; Andy Tsun
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

4.  IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA.

Authors:  Andreas Pichlmair; Caroline Lassnig; Carol-Ann Eberle; Maria W Górna; Christoph L Baumann; Thomas R Burkard; Tilmann Bürckstümmer; Adrijana Stefanovic; Sigurd Krieger; Keiryn L Bennett; Thomas Rülicke; Friedemann Weber; Jacques Colinge; Mathias Müller; Giulio Superti-Furga
Journal:  Nat Immunol       Date:  2011-06-05       Impact factor: 25.606

5.  Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.

Authors:  Jon D Reuter; Beatriz E Vivas-Gonzalez; Daniel Gomez; Jean H Wilson; Janet L Brandsma; Heather L Greenstone; John K Rose; Anjeanette Roberts
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein.

Authors:  Chad E Mire; Derek Dube; Sue E Delos; Judith M White; Michael A Whitt
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

7.  A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.

Authors:  Anasuya Chattopadhyay; Eryu Wang; Robert Seymour; Scott C Weaver; John K Rose
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

8.  Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.

Authors:  Kazu Okuma; Kevin P Dalton; Linda Buonocore; Elizabeth Ramsburg; John K Rose
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.

Authors:  David A Coil; A Dusty Miller
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins.

Authors:  Linda Buonocore; Keril J Blight; Charles M Rice; John K Rose
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.